Tier C · Early / limited human evidence
Sermorelin
A shorter GHRH analog with a long history in human endocrine research.
Why researchers care
Potential human relevance
- Stimulates endogenous growth hormone release
- Has been studied in children with growth disorders and older adults
- Human studies show activation of the somatotropic axis
What the human evidence says
Evidence, not extrapolation
Sermorelin/GHRH(1-29) has clear human physiologic effects and historical clinical use. Modern claims around generalized anti-aging and body composition go beyond the strongest evidence.
How to think about it
The Yooper Peptides take
Its appeal is physiologic: it prompts the pituitary to release GH rather than supplying GH directly.
Primary / authoritative reading